Skip to content
Search

Latest Stories

Flour millers in India want ban on wheat exports

Exports of the grain from India, the world’s second largest producer, increased after Russia’s invasion of Ukraine raised global prices

Flour millers in India want ban on wheat exports

Flour millers' industry body has suggested that India extend a ban on wheat exports that has been in place since last year to help ensure lower domestic prices and adequate stocks for consumers.

Exports of the grain from India, the world's second largest producer, increased after Russia's invasion of Ukraine raised global prices, but a sudden rise in temperatures in March 2022 shrivelled the crop and reduced yields, driving up local prices.


India imposed the ban in May last year, just days after promising to supply large amounts of the grain to a slew of countries suffering from sky-high prices and severe shortages of the staple.

While there is no specific date for the ban to expire, government and industry sources have said it is scheduled to be reviewed next month. Reuters last month reported India was considering extending its term.

"The government's efforts have paid off and local prices have fallen, giving relief to consumers and a wide range of industries, including bread and biscuit makers," said Pramod Kumar, president of the Roller Flour Millers' Federation of India.

"The wheat export ban must continue," he said.

India's new season wheat has just started arriving on the market and the harvest will gather momentum in the next few weeks.

Last month India estimated wheat production in 2023 could rebound to a record 112.2 million tonnes, but some farmers and industry officials are less optimistic due to a sudden rise in temperatures in the past few weeks.

Last year's small crop size led to a 53 per cent drop in government purchases to 18.8 million tonnes, pushing up local prices.

The Food Corporation of India buys wheat to run the world's biggest food welfare programme and to keep a sufficient stockpile to meet any emergency requirements.

(Reuters)

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less